Skip to main content

Biosimilar Market in Europe 2022: Share, Industry Overview, Trends, Opportunities and Forecast to 2027

 According to the latest report by IMARC Group, titled “Biosimilar Market in Europe: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on the biosimilar market in Europe share.

The biosimilar market in Europe reached a value of US$ 6,735 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 25,446 Million by 2027, exhibiting at a CAGR of 22.8% during 2022-2027.

Biosimilars are medical products that are generally manufactured from biological substances, such as microorganisms and animal or plant cells. They are extensively used in the production of vaccines, therapeutic proteins and monoclonal antibodies. Additionally, they are utilized by healthcare professionals for preventing, determining, and treating numerous medical ailments. These products are usually produced under the guidance of licensed facilities that are tracked as an essential part of post-market surveillance. They are considered to be harmless and safe for medical use with minor differences in clinically inactive components.

COVID-19 Impact:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Get a Free Sample Copy of this Report: https://www.imarcgroup.com/europe-biosimilar-market/requestsample

Europe Biosimilar Market Trends:

The market in Europe is primarily driven by the rising prevalence of chronic illnesses due to the sedentary lifestyle patterns of the masses. Additionally, the multiple initiatives undertaken by the governments of numerous countries towards the development of a comprehensive set of stringent regulatory guidelines for biosimilar review are positively influencing the market growth across the region. Furthermore, increasing investments and funding by private and public agencies to upgrade the existing healthcare infrastructure and various technological advancements across the sector are considered to be major growth-inducing factors. Other factors, including the rising awareness regarding the availability of biosimilars among patients, patent expiration of numerous blockbuster biologics and extensive research and development (R&D) activities conducted by key players in biotechnology and medical science, are further projected to drive the market growth across Europe


Europe Biosimilar Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the europe biosimilar market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

  • Novartis
  • Pfizer
  • Teva
  • Celltrion
  • Samsung Bioepis
  • Amgen
  • Apotex
  • Ratiopharm
  • Mylan
  • Merck Sharp & Dohme
  • Eli Lilly
  • Accord Healthcare Ltd
  • Boehringer Ingelheim
  • Hexal Ag
  • Stada Arzneimittel Ag

Key Market Segmentation:

The report has segmented the europe biosimilar market on the basis of country, molecule, indication and manufacturing type.

Breakup by Country:

  • Italy
  • Germany
  • United Kingdom
  • France
  • Spain
  • Others

Breakup by Molecule

  • Infliximab
  • Insulin Glargine
  • Epoetin Alfa
  • Etanercept
  • Filgrastim
  • Somatropin
  • Rituximab
  • Follitropin Alfa
  • Adalimumab

Breakup by Indication

  • Auto-Immune Diseases
  • Blood Disorder
  • Diabetes
  • Oncology
  • Growth Deficiency
  • Female Infertility

Breakup by Manufacturing Type

  • In-house Manufacturing
  • Contract Manufacturing

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/europe-biosimilar-market

Key Highlights of the Report:

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

Comments

Post a Comment

Popular posts from this blog

Gas Pipeline Infrastructure Market 2023: Size, Share, Key Players, Industry Overview, Latest Insights and Forecast to 2028

IMARC Group, a leading market research company, has recently releases report titled “Gas Pipeline Infrastructure  Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028″ , The study provides a detailed analysis of the industry, including the global gas pipeline infrastructure market share , size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market. Report Highlights: How big is the gas pipeline infrastructure market ? Report Attributes Details Market Size in 2022 US$ 2.62 Billion Market Forecast in 2028 US$ 3.38 Billion Growth rate (2023 to 2028) CAGR of 4.10% Base Year of the Analysis 2022 Forecast Period 2023-2028 What is Gas Pipeline Infrastructure? Gas pipeline infrastructure refers to a network of pipelines and associated facilities used to transport natural gas from production areas to end-users. The infrastructure typically includes pipelines of varying ...
Post a Comment
Read more

Biodegradable Diapers Market Size, Demand, Latest Insights, Analysis and Forecast 2022-2027

 According to IMARC Group’s latest report, titled “Biodegradable Diapers Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” the global biodegradable diapers market size reached a value of US$ 3.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 6.2 Billion by 2027, exhibiting at a CAGR of 10.7% during 2022-2027. A diaper is a type of disposable undergarment that allows the wearer, primarily babies and bed-ridden adults, to urinate and defecate without using a toilet. It absorbs and retains the waste, thereby preventing the soiling of external clothing and the environment. Unlike conventional diapers, biodegradable diapers are made from sustainable materials, such as cotton, starch, bamboo, wood pulp, and plant-based gel, while eliminating the use of chlorine and fragrances. They also employ eco-friendly production methods, which enables the components to break down naturally and compost faster. COVID-19 Impact: We...
Post a Comment
Read more

Opioid Use Disorder Market 2023: Share, Growth, Industry Analysis, Trends and Forecast to 2033

IMARC Group, a leading market research company, has recently releases report titled  “Opioid Use Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033“,  offers a comprehensive analysis of the industry, which comprises insights on the  opioid use disorder market growth . The report also includes competitor and regional analysis, and contemporary advancements in the market. Opioid use disorder (OUD) is a medical condition characterized by compulsive drug seeking and use. It comprises prescription painkillers, such as oxycodone and hydrocodone, and illegal drugs. It is associated with intense cravings for opioids, continued use despite negative consequences, withdrawal symptoms when attempting to quit, tolerance, and difficulty controlling or reducing use. It is diagnosed through a comprehensive evaluation of healthcare professionals, such as physical exams, laboratory tests, and a review of the medical and substance use hi...
Post a Comment
Read more